Predictive potential and need for standardization of PD-L1 immunohistochemistry-Reference-Cited by-同舟云学术

Predictive potential and need for standardization of PD-L1 immunohistochemistry

Published:2018-09-01 Issue:4 Volume:474 Page:475-484
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Savic Prince Spasenija,Bubendorf Lukas

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-018-2445-7.pdf

Reference69 articles.

1. US Food and Drug Administration. Pembrolizumab prescribing information https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125514s030lbl.pdf. Accessed June 25 2018

2. European Medicines Agency. Summary of product characteristics: KEYTRUDA (pembrolizumab). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003820/WC500190990.pdf. Accessed June 25 2018

3. US Food and Drug Administration: Nivolumab prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125554s058lbl.pdf. Accessed June 25 2018

4. European Medicines Agency. Summary of product characteristics: OPDIVO (nivolumab). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003985/WC500189765.pdf. Accessed June 25 2018

5. US Food and Drug Administration. Atezolizumab prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041lbl.pdf. Accessed June 25 2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer;Scientific Reports;2024-07-20

2. Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy;Frontiers in Immunology;2024-03-08

3. Localized Imaging of Programmed Death-Ligand 1 on Individual Tumor-Derived Extracellular Vesicles for Prediction of Immunotherapy Response;ACS Nano;2023-10-11

4. Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2023-05-10

5. Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers;Current Oncology;2023-02-16